Curaleaf Holdings (CURLF) Inventory Average (2020 - 2024)
Curaleaf Holdings (CURLF) posted quarterly Inventory Average of $222.1 million for Q4 2024, up 1.91% year-on-year from $217.9 million in Q1 2024, and down 2.56% on a QoQ basis from $227.9 million in Q3 2024.
Curaleaf Holdings (CURLF) Inventory Average (2020 - 2024) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Inventory Average for 5 consecutive years, with $222.1 million the latest figure, recorded in Q4 2024.
- Quarterly Inventory Average rose 1.91% year-over-year to $222.1 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $222.1 million (up 1.91% YoY) and the FY2025 annual result came in at $221.0 million, up 2.1% from the prior year.
- Inventory Average declined to $222.1 million in Q4 2024 per CURLF's latest filing, from $227.9 million in the prior quarter.
- Over the last five years, Inventory Average for CURLF reached as high as $216.9 billion in Q2 2022 and fell as low as $190.4 million in Q4 2020.
- A 5-year average of $33.6 billion and a median of $271.0 million in 2021 frame the typical range for Inventory Average.
- Annual changes were most pronounced in 2022 — Inventory Average jumped 99536.33% — and 2023, when it plunged 46.38%.
- Year by year, Inventory Average stood at $190.4 million in 2020, then surged by 56.05% to $297.2 million in 2021, then rose by 13.23% to $336.5 million in 2022, then tumbled by 35.25% to $217.9 million in 2023, then grew by 1.91% to $222.1 million in 2024.
- According to Business Quant data, Inventory Average over the past three periods registered $222.1 million, $227.9 million, and $217.9 million for Q4 2024, Q3 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.45 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.18 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.51 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 9.02 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 180.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.11 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.96 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 66.75 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.73 Bn |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 222.06 Mn |
| Sep 30, 2024 | 227.89 Mn |
| Dec 31, 2023 | 217.89 Mn |
| Sep 30, 2023 | 232.29 Mn |
| Dec 31, 2022 | 336.50 Mn |
| Sep 30, 2022 | 433.25 Mn |
| Jun 30, 2022 | 216.92 Bn |
| Mar 31, 2022 | 216.83 Bn |
| Dec 31, 2021 | 297.18 Mn |
| Sep 30, 2021 | 325.43 Mn |
| Jun 30, 2021 | 270.95 Mn |
| Mar 31, 2021 | 217.62 Mn |
| Dec 31, 2020 | 190.43 Mn |